Psychiatry & Neurology Doctors in Naples, ME Accepting Medicare
1 Psychiatry & Neurology doctors found. Showing 1 - 1
 Dr. James Mark Krainin, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 15 Krainin Lane, Naples, ME 04055 Phone: 339-206-2278 |
News Archive
Vitro Diagnostics, Mokshagundam Biotechnologies enter contract to develop stem cell-derived food
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced that it has entered into a contract with Mokshagundam Biotechnologies, a private research organization established to develop alternative meat sources, to develop cell culture medium for use in exploration of alternative food sources derived from stem cells.
Center for One Health Illinois to receive additional $500,000 grant from USDA
The Center for One Health Illinois, established at the University of Illinois last year with a $250,000 grant from the U.S. Department of Agriculture, will receive another $500,000 in grants over several years from the USDA to pursue its mission of fostering collaborations and the free flow of information among those in the fields of medicine, public health, the environment and agriculture.
Epizyme commences EPZ-5676 Phase 1 study for MLL-r leukemia
Epizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, announced today that it has initiated a Phase 1 Study of EPZ-5676. EPZ-5676 is a novel small molecule inhibitor of DOT1L, a histone methyltransferase (HMT) that is critical to the development of a specific type of acute leukemia defined by rearrangement of the MLL gene (MLL-r leukemia).
Inhealthcare launches new mobile app to help NHS patients monitor, manage long-term conditions
Digital health specialist Inhealthcare has launched a new mobile app to help NHS patients track, monitor and manage long-term conditions including high blood pressure, diabetes and obesity.
Positive results from BrainStorm's interim NurOwn stem cell therapy clinical trial for ALS
BrainStorm Cell Therapeutics announced today that it has completed the planned interim safety review of its Phase I/II ALS (Amyotrophic Lateral Sclerosis) clinical trial, indicating that autologous transplantation of the Company's cell therapy was well-tolerated, appears to be safe for use, and did not present any undue risks to the study participants.
› Verified 1 days ago